Genetic and proteomic biomarkers in solid tumor detection and treatment

206.5K

views

452

authors

64

articles

Editorial

11 May 2023

Editorial: Genetic and proteomic biomarkers in solid tumor detection and treatment

Jitian Li

,

Apeng Chen

,

Ruowen Zhang

,

Changwei Li

and

Jianguo Zhou

1,457 views

0 citations

Editors

5

Henan Luoyang Orthopedic Hospital (Henan Provincial Orthopedic Hospital)

Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences

Jiahehongsheng (Shenzhen) Health Industry Group

School of Medicine, Shanghai Jiao Tong University

Zunyi Medical University

Impact

Fetching...

About

Cancer is the leading cause of death and remains a great challenge worldwide. The stage at initial diagnosis and the choice of suitable therapy can greatly affect the outcome of cancer patients. Biomarkers can help to identify cancer patients at an earlier stage and guide personalized therapy. Advances in the genomics, transcriptomics, proteomics and metabolomics have significantly improved our understanding of cancer biology. These novel understanding has brought about the evolutionary transformation in personalized cancer therapy and the prognosis of cancer has greatly improved. Molecular biomarkers have played a unique role in cancer management and treatment nowadays.

This Research Topic covers a wide spectrum of studies of genetic and proteomic biomarkers that contribute to the research filed of diagnosis and treatment in solid tumor. Research from laboratories, results from clinical trials or reports of interesting cases are within the scope of current Research Topic. Pure in silico studies without experimental validation will not be considered for this collection.

Potential subtopics are included, but are not limited to:

1. Identification, characterization and validation of genetic and proteomic biomarkers that are associated with solid tumor susceptibility, diagnosis, and therapeutics.

2. Novel techniques for identifying or capturing genetic or proteomic biomarkers in solid tumor.

3. Translational research bridging the gap between our incremental knowledge on the association of solid tumor biomarkers and characteristics, outcome of cancer patient in clinical practice.

4. Case reports of rare cancer types or interesting cases in solid tumor associated with genetic or proteomic biomarkers in clinical practice.

Cancer is the leading cause of death and remains a great challenge worldwide. The stage at initial diagnosis and the choice of suitable therapy can greatly affect the outcome of cancer patients. Biomarkers can help to identify cancer patients at an earlier stage and guide personalized therapy. Advances in the genomics, transcriptomics, proteomics and metabolomics have significantly improved our understanding of cancer biology. These novel understanding has brought about the evolutionary transformation in personalized cancer therapy and the prognosis of cancer has greatly improved. Molecular biomarkers have played a unique role in cancer management and treatment nowadays.

This Research Topic covers a wide spectrum of studies of genetic and proteomic biomarkers that contribute to the research filed of diagnosis and treatment in solid tumor. Research from laboratories, results from clinical trials or reports of interesting cases are within the scope of current Research Topic. Pure in silico studies without experimental validation will not be considered for this collection.

Potential subtopics are included, but are not limited to:

1. Identification, characterization and validation of genetic and proteomic biomarkers that are associated with solid tumor susceptibility, diagnosis, and therapeutics.

2. Novel techniques for identifying or capturing genetic or proteomic biomarkers in solid tumor.

3. Translational research bridging the gap between our incremental knowledge on the association of solid tumor biomarkers and characteristics, outcome of cancer patient in clinical practice.

4. Case reports of rare cancer types or interesting cases in solid tumor associated with genetic or proteomic biomarkers in clinical practice.

Download ebook

Share

Editors

Henan Luoyang Orthopedic Hospital (Henan Provincial Orthopedic Hospital)

Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences

Jiahehongsheng (Shenzhen) Health Industry Group

School of Medicine, Shanghai Jiao Tong University

Zunyi Medical University

Impact

206,474 Total views

123,094 Article views

78,849 Article downloads

4,531 Topic views

Published In

Journal Thumbnail

Frontiers in Genetics

Computational Genomics, Cancer Genetics and Oncogenomics

Journal Thumbnail

Frontiers in Plant Science

Computational Genomics

Journal Thumbnail

Frontiers in Bioengineering and Biotechnology

Computational Genomics

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic